Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases
- PMID: 33458306
- PMCID: PMC7807720
- DOI: 10.1016/j.phro.2020.04.001
Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases
Abstract
In treatment planning, multiple imaging modalities can be employed to improve the accuracy of tumor delineation but this can be costly. This study aimed to compare the interobserver consistency of using dual energy computed tomography (DECT) versus magnetic resonance imaging (MRI) for delineating tumors in the head and neck cancer (HNC) re-irradiation scenario. Twenty-three patients with recurrent HNC and had planning DECT and MRI were identified. Contoured tumor volumes by seven radiation oncologists were compared. Overall, T1c MRI performed the best with median DSC of 0.58 (0-0.91) for T1c. T1c MRI provided higher interobserver agreement for skull base sites and 60 kV DECT provided higher interobserver agreement for non-skull base sites.
Keywords: Delineation; Dual energy computed tomography; Head and neck; Magnetic resonance imaging; Re-irradiation.
© 2020 Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Similar articles
-
Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.J Cancer Res Ther. 2015 Oct-Dec;11(4):746-51. doi: 10.4103/0973-1482.163679. J Cancer Res Ther. 2015. PMID: 26881512
-
Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):80-89. doi: 10.1016/j.ijrobp.2017.05.002. Epub 2017 May 6. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816167 Free PMC article.
-
Dual-energy computed tomography for the detection of late enhancement in reperfused chronic infarction: a comparison to magnetic resonance imaging and histopathology in a porcine model.Invest Radiol. 2011 Jul;46(7):450-6. doi: 10.1097/RLI.0b013e3182145b4f. Invest Radiol. 2011. PMID: 21427592
-
An update on radiation therapy in head and neck cancers.Expert Rev Anticancer Ther. 2018 Apr;18(4):359-364. doi: 10.1080/14737140.2018.1446832. Epub 2018 Mar 1. Expert Rev Anticancer Ther. 2018. PMID: 29485913 Review.
-
An update on advanced dual-energy CT for head and neck cancer imaging.Expert Rev Anticancer Ther. 2019 Jul;19(7):633-644. doi: 10.1080/14737140.2019.1626234. Epub 2019 Jun 21. Expert Rev Anticancer Ther. 2019. PMID: 31177872 Review.
Cited by
-
Multimodal Imaging to Improve Patient Selection and Optimize Treatment Planning and Delivery for Patients Undergoing Reirradiation: A Scoping Review.Curr Oncol Rep. 2025 Aug 20. doi: 10.1007/s11912-025-01708-9. Online ahead of print. Curr Oncol Rep. 2025. PMID: 40830323 Review.
-
Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study.Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):426-436. doi: 10.1016/j.ijrobp.2022.01.050. Epub 2022 Feb 4. Int J Radiat Oncol Biol Phys. 2022. PMID: 35124134 Free PMC article.
-
Clinical benefit of range uncertainty reduction in proton treatment planning based on dual-energy CT for neuro-oncological patients.Br J Radiol. 2023 Sep;96(1149):20230110. doi: 10.1259/bjr.20230110. Epub 2023 Jul 26. Br J Radiol. 2023. PMID: 37493227 Free PMC article.
-
Improving radiation physics, tumor visualisation, and treatment quantification in radiotherapy with spectral or dual-energy CT.J Appl Clin Med Phys. 2022 Jan;23(1):e13468. doi: 10.1002/acm2.13468. Epub 2021 Nov 7. J Appl Clin Med Phys. 2022. PMID: 34743405 Free PMC article. Review.
-
Optimisation and validation of an integrated magnetic resonance imaging-only radiotherapy planning solution.Phys Imaging Radiat Oncol. 2021 Oct 16;20:34-39. doi: 10.1016/j.phro.2021.10.001. eCollection 2021 Oct. Phys Imaging Radiat Oncol. 2021. PMID: 34901474 Free PMC article.
References
-
- Mabanta S.R., Mendenhall W.M., Stringer S.P., Cassisi N.J. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck. 1999;21:591–594. - PubMed
-
- Ng S.P., Phan J. Stereotactic radiotherapy and proton therapy for locally recurrent head and neck cancer. Austin Head Neck Oncol. 2017;1:1002.
-
- De Crevoisier R., Bourhis J., Domenge C., Wibault P., Koscielny S., Lusinchi A. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol. 1998;16:3556–3562. - PubMed
-
- Langer C.J., Harris J., Horwitz E.M., Nicolaou N., Kies M., Curran W. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol. 2007;25:4800–4805. - PubMed
-
- Spencer S.A., Harris J., Wheeler R.H., Machtay M., Schultz C., Spanos W. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck. 2008;30:281–288. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources